Blood-based circular RNAs emerge as a breakthrough early diagnostic tool for Alzheimer's disease
核心洞察
Blood-based circular RNAs (circRNAs) are emerging as a promising non-invasive biomarker for the early diagnosis of Alzheimer's disease (搜索).
The approach builds on a study published in Nature Medicine reporting the use of blood-derived circRNAs for early detection of Alzheimer's disease (搜索).
Early diagnosis addresses a critical unmet need, as amyloid β (搜索) deposition and neurodegeneration can precede cognitive decline in sporadic Alzheimer's disease (搜索).
Blood-based circular RNAs (circRNAs) have emerged as a breakthrough tool for the early diagnosis of Alzheimer's disease (搜索), offering a non-invasive route to detect the condition before substantial cognitive decline occurs. The development, highlighted in a commentary published in The Innovation Neurology, draws on a study by Phillips and colleagues reporting the use of blood-derived circular RNAs for the early diagnosis of Alzheimer's disease, published in Nature Medicine.
The significance of early detection is underscored by the underlying biology of the disease. Amyloid β (搜索) deposition and neurodegeneration are known to precede cognitive decline in sporadic Alzheimer's disease (搜索), as demonstrated in a prospective cohort study by Villemagne and colleagues. This temporal gap between pathological changes and clinical symptoms creates a window in which blood-based biomarkers could enable earlier intervention.
The clinical stakes are considerable. Research by Joling and colleagues has documented the time from diagnosis to institutionalization and death in people with dementia, illustrating the progressive and burdensome course of the disease. A blood-based diagnostic approach that identifies Alzheimer's disease (搜索) earlier could potentially alter this trajectory by enabling timely clinical management.
The commentary situates this advance within a broader shift in the diagnostic landscape. Frisoni and colleagues have described a "new landscape" of Alzheimer's disease (搜索) diagnosis, reflecting evolving approaches to identifying the condition. Blood-based circular RNAs represent a notable addition to this evolving toolkit, offering a minimally invasive alternative to more burdensome diagnostic procedures.
The work originates from the Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education at Northeast Normal University (搜索) in Changchun, China, with corresponding author Nan Gao. The commentary, authored by Licong Chen, Fanshu Sun, Enpeng Xi, and Nan Gao, synthesizes the emerging evidence supporting blood-based circular RNAs as an early diagnostic tool for Alzheimer's disease (搜索).